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Available online 14 September 2016Objective: The aim of this case report was to study that headache maybe the initial symptom in Rasmussen's
syndrome (RS).
Introduction: Headache has not yet been reported as prodromal symptom.
Methods:We studied a case of RS inwhich the patient experienced a recurring headache for about one year prior
to the onset of partial seizures.
Results:Magnetic resonance imaging (MRI) results were normal when the headache ﬁrst occurred and showed
left brain atrophy three years later. It was difﬁcult to relieve the patient's headache, even once seizures were
controlled.
Conclusions: This case demonstrates that the initial symptom of RS may involve only headache.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Child1. Introduction
Rasmussen syndrome (RS), also called Rasmussen's encephalitis, is a
chronic T-cell-mediated disorder that usually affects one cerebral hemi-
sphere, and that typically presents in childhood. In 2005, a panel of
experts established formal RS diagnostic criteria [1]. The nonspeciﬁc pro-
dromal period lasts for about 7 months (range: 0months to 8 years) and
may involve mild signs and symptoms, typically including low frequent
focal onset seizures and rarely mild hemiparesis. In the subsequent
acute phase, which lasts for about 8 months (range, 4–8 months), fre-
quent focal onset seizures occur, sometimes presenting with epilepsia
partialis continua (EPC), accompanied by progressive cortical dysfunc-
tion. Finally, patients in the residual stage exhibit stable neurologic deﬁ-
cits and continuation of seizures [1]. However, some cases involve
atypical features, manifesting absence or delayed-onset seizures, and
dual pathology, suggesting that focal onset seizures are not necessary
for RS diagnosis [2].
We reported a case of RS in a child who presented with the initial
onset of headache, and who later was admitted to the hospital several
times with the chief complaint of headache, even after her seizures
were controlled.al of China Medical University,
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A nine-year-old girl with normal development presented with a
headache and a feeling like her whole head was expanded without
localizing characteristics, unaccompanied by nausea or vomiting, and
having no obvious etiology about ﬁve years ago. The headache was
mild and could remit spontaneously, but repeat about ﬁve times, each
time with a duration of about 15 days. Magnetic resonance imaging
(MRI) results were normal at this time.
One year after the onset of headache, this patient experienced a
headache that lasted for several hours, with a 2-minute generalized
tonic–clonic seizure beginning about 3 h after the onset of headache.
After this incident, the patient frequently experienced focal motor
seizures involving the right lower limb without losing consciousness.
Electroencephalograph (EEG) conﬁrmed the presence of epileptiform
discharge with increased slow waves in the whole brain without focal
abnormalities. Epilepsy was diagnosed, and levetiracetam (about
20 mg/kg/d, twice a day) was prescribed.
The patient's symptoms showed no improvement after taking oral
levetiracetam for about two months. At this time, the patient was ad-
mitted to the hospital for detailed laboratory and ancillary testing.
Brain MRI revealed abnormal signal foci in the left frontal cortex, and
EEG showed diffuse slowing with epileptiform discharge in the left
hemisphere. Lumbar puncture revealed normal cerebral spinal ﬂuid
(CSF) cell count, protein, glucose, chloride, and cryptococcal meningiti-
des. Blood test results were normal for ceruloplasmin, lactic acid,
ammonia, immunoglobulins (IgA, IgM, IgG), rheumatoid factor (RF),
antistreptolysin O (ASO), C-reactive protein, autoantibody to nuclearthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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double-stranded DNA (anti-dsDNA) were negative.
Rasmussen syndrome (RS) was diagnosed according to the diagnos-
tic criteria (Part A) [1]. The patient received IV methylprednisolone
(25 mg/kg/d) pulse therapy for three days and intravenous
immunoglobin (IVIG, 400 mg/kg/d) for ﬁve days. The patient also re-
ceived oral prednisone (1 mg/kg/d, three times a day), carbamazepine
(10 mg/kg/d, twice a day), and phenobarbital (10 mg/kg/d, three
times a day) for seizures, and oxycodone–acetaminophen (oxycodone
5 mg with acetaminophen 325 mg per tablet, one tablet three times a
day as needed) for headache. After about ﬁve months, the seizures
stopped, and the patient's parents discontinued the patient's antisei-
zuremedicationwithout consent from the doctors. After approximately
half a year without headache and focal seizures, the headache and focal
seizures resumed. The headache was moderate in intensity and hard to
be tolerated at times. Ibuprofen had been tried and did not work.
Occasional skin rash developed when the patient was treated with car-
bamazepine, and this was a reason for the discontinuation of treatment.
The patient was then prescribed sodium valproate sustained release
tablets (20 mg/kg/d) and oxycodone–acetaminophen (one tablet
three times a day as needed), with follow-up every three months, and
with blood concentration of sodium valproate maintained at around
90 μg/ml. Three years after the onset of headache, brain MRI (Fig. 1a)
showed atrophy of the left frontal temporal lobe and deep gray matter,
large patchy hypointensities on T1 and increased T2 signals, and bilater-
al ventricular enlargement.
The headache disappeared and the patient was seizure-free for
about 2 years and 6 months, at which time the treatment with sodium
valproate and oxycodone–acetaminophen was stopped. After about
6 months without symptoms, the headache resumed, and the patient
was hospitalized again. The headache was mild to moderate and could
be tolerable, and only localized in the left unilateral head region. At
this time, the patient also showed gait instability. BrainMRI (Fig. 1b) re-
vealed atrophy of the left cerebral hemisphere, with this space occupied
by abnormal T1 and T2 signals, as well as enlargement of the third and
fourth ventricles and the left ventricle. Physical examination showedFig. 1. The brainMRI images. (a) BrainMRI after three years after the onset of headache and two
deep graymatter, with large patchy abnormalities on T1 and T2 sequenceswith bilateral ventri
after the onset of focal seizures shows atrophy of the left cerebral hemisphere, with this space o
left ventricle.clear consciousness; dysarthria; defects in calculation ability; weakness
of the right lower limb; decreased grip strength of the right hand; slight-
ly enhanced muscular tone of the right limbs; and normal movement,
strength, and muscular tone in the left limbs. The patient's right
Babinski sign was positive, and the left one was negative. A consulted
neurosurgeon advised that the patient was not an optimal candidate
for surgical treatment. Because of concerns regarding side effects of cor-
ticosteroids, IVIG (400 mg/kg/d) was administered for 5 days with the
informed consent of her parents. The headaches eased, but dyskinesia
in the right limbs remained, and oral oxycodone–acetaminophen was
administered again.
3. Discussion
In RS, the initial damage to the brain is mediated by T cells and mi-
croglia, and there may be a window for treatment if RS is diagnosed
early enough. Inﬂammatory processes observable withMRI can support
an RS diagnosis [2], and early diagnosis may be easier in typical cases
that closely alignwith thediagnostic criteria. On the other hand, diagno-
sis remains challenging in some atypical cases, as there are not yet diag-
nostic biomarkers available.
In our present case, the patient suffered from headaches for about
one year prior to her ﬁrst focal seizure. Headaches without functional
loss are very common among children and are often due to migraines
in the absence of abnormalities upon ancillary testing [3]. Thus, a diag-
nosis of RS was not suspected in our case during the ﬁrst year. We can-
not conﬁrm that the headaches in our case were speciﬁcally symptoms
of RS, but some pathogenic factors for RSmay also stimulate headaches.
It is possible that some cases of RS may have the same pathogenesis as
some headaches, and that analyzing headaches in RS may represent a
new route to clarifying RS pathogenesis.
The headache could appear and disappear without treatment at the
start, and then became a concomitant symptomwhen the patientwas di-
agnosedwith epilepsy.When theheadache relapsed the third time, itwas
hard to tolerated, and then oxycodone–acetaminophen was prescribed.
Oxycodone–acetaminophen (oxycodone 5 mg with acetaminophenyears after the onset of partial seizures reveals atrophy of the left frontal temporal lobe and
cular enlargement. (b) BrainMRI after ﬁve years after the onset of headache and four years
ccupied by T1 and T2 signal lesionswith enlargement of the third and fourth ventricles and
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opioid (oxycodone) with a nonopioid (acetaminophen) component . The
intensity and frequency of headachewere decreased, and the patientwas
headache free after about two weeks.
Immunomodulatory treatments, such as corticosteroids and/or IVIG,
appear to slow but not halt disease progression, without substantially
changing the eventual outcome. During the ﬁrst year in our case, head-
acheswithout any concomitant symptoms could be relieved by rest, like
migraines, and did not show any speciﬁc characteristics indicating their
cause. Thus, these headaches could not be identiﬁed as prodromal
symptoms of RS at that time. Only once seizures occurred during the
headaches did we consider that RS and the headache were symptoms
of the same disease. From then on, headaches and focal seizures were
due to the same complaints and, over time, the headache could no lon-
ger be relieved without medication. In the ﬁnal stage, the headache
changed to only involve the side of brain injury. Based on the evolution
of the headache with the disease progression, we conclude that the ini-
tial headache was a presenting symptom of RS.
Here, we reported an RS case that started with repetitive headaches,
adding to the current body of knowledge about RS. Rasmussen syn-
drome (RS) without seizures is considered a potentially under-recog-
nized cause of progressive unilateral neurological deﬁcits in childhood
[4]. Thus, it is important to diagnose atypical cases, even if we can pres-
ently only delay but not halt RS progression. This requires recognizing
early possible signs and making follow-up observations. In our case,
follow-up was inadequate for the ﬁrst two years because the patient's
parents did not understand the natural history of the disease process.Regular follow-upwas performed only after conﬁrmation of cerebral le-
sions identiﬁed on brain MRI.
Because of the outcome of RS, in cases involving differential diagno-
ses of headaches, it is important to consider some rare diseases, such as
RS.We think that follow-up for headache patients is important to verify
the cause or diagnosis. In our experience, we suggest that repeated
brain MRI and EEG examinations should be considered to re-evaluate
the headache causes even when the examinations were normal previ-
ously. In addition to re-evaluating patients with ancillary testing when
new symptoms arise such as with new onset seizures.
Atypical RS is hard to diagnosed immediately. Our single case cannot
serve as an example of what is typical, but our observations suggest that
the initial syndrome of RSmay involve only headache. Thoughwhile RS
is not presently curable, we hope to help promote early diagnosis and
prompt treatment to delay disease progression.
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